Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034796150> ?p ?o ?g. }
- W3034796150 endingPage "31123" @default.
- W3034796150 startingPage "31112" @default.
- W3034796150 abstract "Platforms for enzyme delivery must simultaneously have plasma stability, high catalytic activity, and low/no immunogenicity of the enzyme. Here, we designed a novel biomimetic membrane-structured nanovesicle (BNV) to efficiently carry supramolecular enzymes to meet the above requirements. We complexed l-asparaginase (Aase) with hydroxypropyl-β-cyclodextrin (HPCD) to form a supramolecular amphiphile (AS) by self-assembly via noncovalent reversible interactions. We then used the first synthesized polyethylene glycol (PEG 2 kDa)-decorated hyaluronan (12 kDa) and HPCD to self-assemble a semipermeable biomimetic membrane-structured nanovesicle (BNV) together with AS loading. As compared to native Aase, AS@BNV exhibited superior catalytic activity preservation, improved catalytic activity, better pharmacokinetics in rats, enhanced cytotoxic effects, increased antitumor efficacy, and decreased side effects. The underlying mechanisms, such as the autophagy inhibition action against tumor cells, protein–protein docking of the interaction between Aase–serum albumin, and decreased hepatic enzymatic activity, were investigated. This approach paves the way for new types of powerful biomimetic-, supramolecular-, and nanocarrier-based enzymatic therapies." @default.
- W3034796150 created "2020-06-19" @default.
- W3034796150 creator A5001970471 @default.
- W3034796150 creator A5002418737 @default.
- W3034796150 creator A5005298628 @default.
- W3034796150 creator A5005669125 @default.
- W3034796150 creator A5010495537 @default.
- W3034796150 creator A5027237951 @default.
- W3034796150 creator A5038598323 @default.
- W3034796150 creator A5046409585 @default.
- W3034796150 creator A5054723411 @default.
- W3034796150 creator A5064101943 @default.
- W3034796150 creator A5068947466 @default.
- W3034796150 creator A5072948474 @default.
- W3034796150 creator A5076288922 @default.
- W3034796150 date "2020-06-16" @default.
- W3034796150 modified "2023-10-16" @default.
- W3034796150 title "Biomimetic Membrane-Structured Nanovesicles Carrying a Supramolecular Enzyme to Cure Lung Cancer" @default.
- W3034796150 cites W1813502703 @default.
- W3034796150 cites W1966457743 @default.
- W3034796150 cites W1975348828 @default.
- W3034796150 cites W1984548348 @default.
- W3034796150 cites W2027186446 @default.
- W3034796150 cites W2044315307 @default.
- W3034796150 cites W2046682217 @default.
- W3034796150 cites W2047886533 @default.
- W3034796150 cites W2050460466 @default.
- W3034796150 cites W2056609366 @default.
- W3034796150 cites W2066439646 @default.
- W3034796150 cites W2068950399 @default.
- W3034796150 cites W2072059424 @default.
- W3034796150 cites W2117321286 @default.
- W3034796150 cites W2123382909 @default.
- W3034796150 cites W2126265982 @default.
- W3034796150 cites W2157938818 @default.
- W3034796150 cites W2273354125 @default.
- W3034796150 cites W2296983466 @default.
- W3034796150 cites W2304537205 @default.
- W3034796150 cites W2414091947 @default.
- W3034796150 cites W2512678052 @default.
- W3034796150 cites W2531392751 @default.
- W3034796150 cites W2586672288 @default.
- W3034796150 cites W2592840643 @default.
- W3034796150 cites W2597896859 @default.
- W3034796150 cites W2610139719 @default.
- W3034796150 cites W2621753584 @default.
- W3034796150 cites W2740618823 @default.
- W3034796150 cites W2746436699 @default.
- W3034796150 cites W2751685013 @default.
- W3034796150 cites W2753581915 @default.
- W3034796150 cites W2774248760 @default.
- W3034796150 cites W2775053603 @default.
- W3034796150 cites W2788285407 @default.
- W3034796150 cites W2791844198 @default.
- W3034796150 cites W2792570735 @default.
- W3034796150 cites W2793483446 @default.
- W3034796150 cites W2796274297 @default.
- W3034796150 cites W2800356358 @default.
- W3034796150 cites W2807002237 @default.
- W3034796150 cites W2808082897 @default.
- W3034796150 cites W2808315564 @default.
- W3034796150 cites W2887494872 @default.
- W3034796150 cites W2892735968 @default.
- W3034796150 cites W2898772297 @default.
- W3034796150 cites W2906257694 @default.
- W3034796150 cites W2906652495 @default.
- W3034796150 cites W2911188335 @default.
- W3034796150 cites W2940447007 @default.
- W3034796150 cites W2945385843 @default.
- W3034796150 cites W2948864844 @default.
- W3034796150 cites W2950418272 @default.
- W3034796150 cites W2950955288 @default.
- W3034796150 cites W2952467237 @default.
- W3034796150 cites W2956057689 @default.
- W3034796150 cites W2962184187 @default.
- W3034796150 cites W2962196100 @default.
- W3034796150 cites W2991642144 @default.
- W3034796150 cites W3010779438 @default.
- W3034796150 cites W3027919216 @default.
- W3034796150 doi "https://doi.org/10.1021/acsami.0c06207" @default.
- W3034796150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32544316" @default.
- W3034796150 hasPublicationYear "2020" @default.
- W3034796150 type Work @default.
- W3034796150 sameAs 3034796150 @default.
- W3034796150 citedByCount "15" @default.
- W3034796150 countsByYear W30347961502021 @default.
- W3034796150 countsByYear W30347961502022 @default.
- W3034796150 countsByYear W30347961502023 @default.
- W3034796150 crossrefType "journal-article" @default.
- W3034796150 hasAuthorship W3034796150A5001970471 @default.
- W3034796150 hasAuthorship W3034796150A5002418737 @default.
- W3034796150 hasAuthorship W3034796150A5005298628 @default.
- W3034796150 hasAuthorship W3034796150A5005669125 @default.
- W3034796150 hasAuthorship W3034796150A5010495537 @default.
- W3034796150 hasAuthorship W3034796150A5027237951 @default.
- W3034796150 hasAuthorship W3034796150A5038598323 @default.
- W3034796150 hasAuthorship W3034796150A5046409585 @default.
- W3034796150 hasAuthorship W3034796150A5054723411 @default.